Morgan Stanley lowered the firm’s price target on Accelerant (ARX) to $16 from $17 and keeps an Equal Weight rating on the shares. The firm updated its model to incorporate the latest Q4 results and management guidance from the earnings call. Morgan Stanley slightly increased its topline growth, partially offset by slightly lower adjusted EBITDA margins.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARX:
- Accelerant price target lowered to $16.50 from $22.50 at BMO Capital
- Accelerant upgraded to Overweight from Equal Weight at Wells Fargo
- Accelerant Holdings Reports Strong Results and CFO Transition
- Accelerant reports Q4 adjusted EPS 23c, consensus 22c
- Accelerant board authorizes up to $200M share repurchase program